兴齐眼药
(300573)
| 流通市值：136.85亿 | | | 总市值：178.17亿 |
| 流通股本：1.88亿 | | | 总股本：2.45亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,162,742,877.58 | 536,140,697.03 | 1,943,387,835.59 | 1,439,292,774.15 |
| 营业收入 | 1,162,742,877.58 | 536,140,697.03 | 1,943,387,835.59 | 1,439,292,774.15 |
| 二、营业总成本 | 779,972,185.27 | 367,431,795.47 | 1,543,949,382.84 | 1,107,360,765.17 |
| 营业成本 | 224,704,634.68 | 106,395,143.17 | 421,112,533.31 | 311,135,831.8 |
| 税金及附加 | 16,274,403.57 | 7,638,522.54 | 25,424,342.81 | 19,772,652 |
| 销售费用 | 366,101,237.17 | 168,013,751.13 | 705,486,097.79 | 516,894,927.53 |
| 管理费用 | 77,895,153.89 | 37,360,837.2 | 170,293,369.66 | 120,230,507.73 |
| 研发费用 | 91,760,465.26 | 47,072,206.09 | 220,658,226.68 | 139,482,476.89 |
| 财务费用 | 3,236,290.7 | 951,335.34 | 974,812.59 | -155,630.78 |
| 其中:利息费用 | 2,803,405.09 | 1,500,603.87 | 5,712,779.97 | 4,067,163.28 |
| 其中:利息收入 | 1,390,970.39 | 718,880.16 | 5,657,544.82 | 4,750,007.83 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | -24,241.4 | -24,241.4 |
| 资产处置收益 | 74,796.81 | 32,097.59 | -978,359.46 | 101,666.52 |
| 资产减值损失(新) | -7,641,667.71 | -6,401,087.37 | -3,416,753.32 | -3,095,292.59 |
| 信用减值损失(新) | -1,148,966.11 | -370,827.37 | -4,619,519.38 | -3,267,560.09 |
| 其他收益 | 21,740,080.8 | 16,176,559.16 | 34,350,960.87 | 26,662,744.62 |
| 四、营业利润 | 395,794,936.1 | 178,145,643.57 | 424,750,540.06 | 352,309,326.04 |
| 加:营业外收入 | 83,758 | 905 | 291,891.24 | 247,331.5 |
| 减:营业外支出 | 11,172,467.98 | 612,655.4 | 30,011,145.88 | 14,697,571.41 |
| 五、利润总额 | 384,706,226.12 | 177,533,893.17 | 395,031,285.42 | 337,859,086.13 |
| 减:所得税费用 | 49,880,171.32 | 31,638,569.37 | 56,969,508.83 | 47,096,227.63 |
| 六、净利润 | 334,826,054.8 | 145,895,323.8 | 338,061,776.59 | 290,762,858.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 334,826,054.8 | 145,895,323.8 | 338,061,776.59 | 290,762,858.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 334,826,054.8 | 145,895,323.8 | 338,061,776.59 | 290,762,858.5 |
| 扣除非经常损益后的净利润 | 330,984,652.17 | 136,016,935.16 | 347,542,460.02 | 289,703,585.69 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.36 | 0.83 | 1.94 | 1.67 |
| (二)稀释每股收益 | 1.36 | 0.83 | 1.93 | 1.67 |
| 九、综合收益总额 | 334,826,054.8 | 145,895,323.8 | 338,061,776.59 | 290,762,858.5 |
| 归属于母公司股东的综合收益总额 | 334,826,054.8 | 145,895,323.8 | 338,061,776.59 | 290,762,858.5 |
| 公告日期 | 2025-08-28 | 2025-04-29 | 2025-04-22 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |